Antiepileptic — Sodium Channel Blocker
Pregnancy: Avoid — teratogenic risk; MHRA Valproate-like programme not implemented but folate supplementation essential. Use reliable contraception.
Oxcarbazepine
Brand names: Trileptal
Adult dose
Dose: 300 mg twice daily initially; usual maintenance 600–1200 mg twice daily
Route: Oral
Frequency: Twice daily
Max: 2400 mg/day
Structural analogue of carbamazepine — fewer drug interactions (not CYP3A4 inducer to same degree) and better tolerated. Licensed for focal seizures with or without secondary generalisation. Also used for trigeminal neuralgia. Monitor sodium — hyponatraemia is the key side effect.
Paediatric dose
Dose: 8–10 mg/day/kg
Route: Oral
Frequency: Twice daily
Max: 46 mg/kg/day
Children ≥6 years: start 8–10 mg/kg/day in 2 divided doses. Maximum 46 mg/kg/day.
Dose adjustments
Renal
Reduce starting dose by 50% if eGFR <30 mL/min — active metabolite (MHD) renally excreted.
Hepatic
No adjustment in mild–moderate impairment. Avoid in severe hepatic impairment.
Paediatric weight-based calculator
Children ≥6 years: start 8–10 mg/kg/day in 2 divided doses. Maximum 46 mg/kg/day.
Clinical pearls
- MHRA: test for HLA-B*1502 allele before starting in patients of Han Chinese or Thai origin — high risk of SJS/TEN
- Hyponatraemia is the cardinal monitoring parameter — occurs in up to 25% of patients; clinically significant (<125 mmol/L) in ~3%
- Advantage over carbamazepine: fewer drug interactions and less enzyme induction — preferred when complex polypharmacy present
Contraindications
- AV block
- Hypersensitivity to oxcarbazepine or carbamazepine (25–30% cross-reactivity)
Side effects
- Hyponatraemia (clinically significant — check Na regularly)
- Dizziness and diplopia
- Nausea
- Rash (SJS/TEN risk — HLA-B*1502 in Han Chinese/Thai populations)
- Sedation
- Hyponatraemia more common than with carbamazepine
Interactions
- Combined oral contraceptives (CYP induction — contraception failure; use additional method)
- Phenytoin (increases phenytoin levels)
- Carbamazepine (additive CNS effects)
- Lithium (additive hyponatraemia risk)
Monitoring
- Serum sodium at baseline and 3 months then 6-monthly
- LFTs at baseline
- FBC
- AED levels not routinely measured (MHD level available if needed)
Reference: BNFc; BNF 90; NICE NG217 (Epilepsies in children and adults); MHRA Oxcarbazepine Safety Update; BNFc. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS